VB Spine Moves to Secure Exclusive Rights to Augmedics’ Spine Technology Platform
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement to acquire…
DeciBio Consulting Unveils Data Report on Oncology Genomics Trends Across Europe
Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and…
Worldwide Clinical Trials Finalizes Acquisition of Catalyst Clinical Research
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research Worldwide Clinical Trials a global contract research organization (CRO), has completed its acquisition of Catalyst Clinical Research, LCC (“Catalyst”) – a specialized oncology CRO and scalable functional…
ECCO Data Highlight Remsima™ SC’s Ability to Restore and Sustain Disease Control After Treatment Break
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday Celltrion, Inc. today announced new data from a post-hoc analysis of the pivotal…
Genentech Highlights Breakthrough Phase III Results for Gazyva in Autoimmune Kidney Disease
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease Genentech, a member of the Roche Group announced today that…
Quantum-Si Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that…
Promega Presents Breakthrough Cellular Target Engagement Platform at SLAS 2026
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026 Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap…
Arintra Slashes Coding Expenses and Achieves Strong Retention with 8X Revenue Expansion
Arintra Cuts Coding Costs by Nearly One-Third for Customers, Driving Industry-Leading Retention and 8X Revenue Growth Arintra, the leading GenAI-native autonomous medical coding platform for healthcare organizations, today announced it…
Corazon, Columbia HeartSource Introduce First-of-Its-Kind Open-Heart Surgery Accreditation
Corazon and Columbia HeartSource Announce Partnership Offering First-of-its-Kind Open-Heart Surgery Accreditation Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery and Division of Cardiology and Corazon, a…
RxERP, p-Chip Corporation Partner on Licensing Agreement to Support DSCSA Compliance
RxERP and p‑Chip Corporation Announce Licensing Agreement to Enable Embedded Unit‑Level Digital Identity for DSCSA Compliance and End‑to‑End Pharmaceutical Traceability RxERP, a cloud-hosted, pharmaceutical-first ERP platform, and p‑Chip Corporation (“p‑Chip”),…
Australian Breast Cancer Innovators Secure $27M in Private Funding Round
Australian Breast Cancer Innovators Close $27M Private Funding Round OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and…
KalVista Pharmaceuticals Showcases EKTERLY® Data at AAAAI 2026 Annual Meeting
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals, Inc. today announced the acceptance of three abstracts for presentation at…